Update to the Permissible Ingredients Determination (No. 3 of 2023)

This Technical Alert contains all details of new, deleted and changed ingredients, and a comparison table of all changes to the Determination for members. Please note that the information in this alert is included in a comparison table and is more detailed than the description published on the TGA website.

This alert details:

NEW ingredients

The addition of the following new ingredients for use in listed and assessed listed medicines.

– Addition of the new ingredient, refined Buglossoides arvensis seed oil, for use in listed and assessed listed medicines, with exclusive use provisions for 2 years;

– Addition of the new ingredient, chicken sternum cartilage powder, for use in listed and assessed listed medicines, with exclusive use provisions for 2 years;

CHANGED ingredients 

– Correction of a minor typographical error in the wording of the restriction for the ingredient, violet leaf absolute, in relation to its use as a fragrance;

– Correction of the spelling for the ingredient “Saccharomyces cervisiae polysaccharides” to “Saccharomyces cerevisiae polysaccharides”; and

REMOVED  ingredients 

– Resolution of the duplicate ingredients, “Poloxamine” a

LinkedIn
Facebook
Twitter
Email

RECENT ARTICLES

Vale Stephen Myers

It is with great sadness that we learned of the passing of Emeritus Professor Stephen Myers late last week. Stephen was a giant in the

Read More